Hangzhou Tigermed Consulting Company Ltd (PK) (HTMDF) Quote

Way too many words, the market speaks but I do understand that the MMs now are alerted to the price rise and want to help out their buddies, so I would expect either a sharp rise in price with an eventual sharp decline....notice the price ranges in price which indicates the use of "exempted short se

Thank you for this. Perhaps Dupixent should be looking at us for their AI. That should be an easy sell for HALO.

Phantom stock...provide employers with a means of providing equity-linked compensation to employees without the need to materially dilute their stock.

https://www.investopedia.com/articles/stocks/12/introduction-phantom-stock.asp

IVP more volatility expected
https://investorshub.advfn.com/uimage/uploads/2024/7/9/cbojoIMG_9435.gif

BEEM off a 52week low
https://investorshub.advfn.com/uimage/uploads/2024/7/9/fquapIMG_9434.gif

Mkt Recap----Mkt open ES at upper T/L of now 5 day Rising Channel----4 tests of Da ES 5 min Red Line---ending with an upside wedge B/O at 12.35 with dual 5 min ES & SPX 5 min CCI buy Sigs ---now after mkt retesting upper T/L !!----Another Wedge Day !!

" As of November 14, 2023, the Company had 365,418,647, shares of common stock, $0.001 par value, issued and outstanding."
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000849636/000149315223041875/form10-q.htm

"Outstanding Shares
836,427,843
06/05/2024"

This proves one thing.

Can't fix stupid.

YMIGH..............STAY TUNED!!!!!!!!!!

Haven’t diluted?

" As of November 14, 2023, the Company had 365,418,647, shares of common stock, $0.001 par value, issued and outstanding."
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000849636/000149315223041875/form10-q.htm

"Outstanding Shares
836,4

Lexaria will be testing Tirzepatide as soon as they receive Independent Review Board approval. GLP-1-H24-3
https://www.msn.com/en-ca/health/other/a-weight-loss-miracle-new-shot-does-better-than-ozempic-and-wegovy-during-trials/ar-BB1pDadQ?ocid=msedgntp&pc=DCTS&cvid=79441a3371884b27af6113da05f

A day closer to the EM, and still no fins, no updates no nothing.
Other than the endless posts of "things are great, nothing to see here".
Both RNVA & FOXO are doing nothing. Add to that, the nothing coming from this tickers CEO...and you have what we have here. A ticker that is on th

SPX PIVOTS: Pivot--5572----R1--5583----R2--5593----R3--5604-----S1--5562----S2--5551----S3--5541 !

What ever happened to that COVID P&D stock???? .0000000000000001 but yet they troll here

100% correct.
We are the majority and we are holding strong And there is nothing they can do about it other than post on this board 24/7 for the last 5 years. This is their strategy…. BwahahAHAHAWahah
MAJORITY HOLDING STRONGER

I´ve these obvious ridiculous noisemakers/weisenheimers/FUD-spreaders all together (actually just 2 with their meanwhile wellknown agenda) on ignore.Typical, classical IHUB bashers like textbook! Hilarious!
Edit: Forgot that one of the 2 at least is so honest admitting being a shareholder - k

You mean Kiwi was wrong about Epadel waiting in the wings? Say it isn’t so….
It took Amarin and Eddingpharm years it seems to get China to approve Vazkepa.

Now all of a sudden “Mr Facto” blundered? The master of the innuendo.

Do the Chinese like the Japs? I mea

A much bigger threat from Beryl was

dodged...

Beryl injested dry air for almost

two days before landfall...

Beryl intensity increase from tropical

storm to hurricane only had about

six to eight hours to get the

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174722632

with a 4 billion injection from VW, Rivian may be one of the few electric vehicles to be successful but its going to take a few years.....

IHUB privacy can be more like Public Commons.

Well at times anyway, sounds like you're probably signed out. I think if you sign back into IHUB things might look differently and more desireable.

More oure wish then knowledge

In yesterdays' tweet: IRB established.

The Institutional Review Board reviews and monitors biomedical research involving human subjects (Halberd is conducting clinical trials on Veterans and active duty personel). In accordance with FDA regulations, an IRB has the authority to approve